Biogen Idec is expecting to launch Plegridy (peginterferon beta-1a) in the UK at the end of November 2014. Plegridy is indicated for the treatment of relapsing-remitting multiple sclerosis. It is a modified version of interferon beta 1a which is long-acting and so requires injection once every two weeks. List price for pack of two 125 μg injections, £654.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20067135
Recommended from Pharmaceutical Press
Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.Visit rpharms.com